Abstract:Background-Severe cardiac hypertrophy can lead to cardiac remodeling and even heart failure in the end, which is a leading cause of cardiovascular disease-related mortality worldwide. A disintegrin and metalloprotease-22 (ADAM22), a member of the transmembrane and secreted metalloendopeptidase family, participates in many biological processes, including those in the cardiovascular system. However, there is no explicit information on whether ADAM22 can regulate the process of cardiac hypertrophy; the effects that ADAM22 exerts in cardiac hypertrophy remain elusive. Methods and Results-We observed significantly increased ADAM22 expression in failing hearts from patients with dilated cardiomyopathy and hypertrophic cardiomyopathy; the same trend was observed in mice induced by transaortic constriction and in neonatal rat cardiomyocytes treated by angiotensin II. Therefore, we constructed both cardiac-specific ADAM22 overexpression and knockout mice. At 4weeks after transaortic constriction, cardiac-specific ADAM22 knockout, by the CRISPR/Cas9 (clustered regularly interspaced palindromic repeat (CRISPR)-Cas9) system, deteriorated the severity of cardiac hypertrophy in mice, whereas cardiac-specific ADAM22 overexpression mitigated the degrees of cardiac hypertrophy in mice. Similarly, altered ADAM22 expression modulated the angiotensin II-mediated cardiomyocyte hypertrophy in neonatal rat cardiomyocytes. After screening several signaling pathways, we found ADAM22 played a role in inhibition of protein kinase B (AKT) activation. Under the cardiac-specific ADAM22 knockout background, AKT activation was enhanced in transaortic constriction-induced mice and angiotensin II-stimulated neonatal rat cardiomyocytes, with a severe degree of cardiac hypertrophy. Treatment of a specific AKT inhibitor attenuated the transaortic constriction-enhanced AKT activation and cardiac hypertrophy in mice. Conclusions-The findings demonstrated that ADAM22 negatively regulates the AKT activation and the process of cardiac hypertrophy and may provide new insights into the pathobiological features of cardiac hypertrophy.

AKT2 Deficiency Induces Retardation of Myocyte Development Through EndoG-MEF2A Signaling in Mouse Heart

Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice.

AKT2 Regulates Development and Metabolic Homeostasis Via AMPK-depedent Pathway in Skeletal Muscle

Deletion of Akt1 Causes Heart Defects and Abnormal Cardiomyocyte Proliferation

Phosphoinositide-Dependent Kinase 1 And Mtorc2 Synergistically Maintain Postnatal Heart Growth And Heart Function In Mice

Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension

Akt2 deficiency alleviates oxidative stress in the heart and liver during high fat diet-induced obesity

A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.

Akt2 Deficiency Alleviates Oxidative Stress in the Heart and Liver Via Up-Regulating SIRT6 During High-Fat Diet-Induced Obesity

AKT2 Deficiency Causes Sarcopenia and Metabolic Disorder of Skeletal Muscle

AKT2 Deficiency Alleviates Doxorubicin-induced Cardiac Injury via alleviating oxidative stress in cardiomyocytes

Combined Cardiomyocyte PKCδ and PKCε Gene Deletion Uncovers Their Central Role in Restraining Developmental and Reactive Heart Growth

Activation of Akt Rescues Endoplasmic Reticulum Stress-Impaired Murine Cardiac Contractile Function Via Glycogen Synthase Kinase-3Β-mediated Suppression of Mitochondrial Permeation Pore Opening.

Actn2 defects accelerates H9c2 hypertrophy via ERK phosphorylation under chronic stress

Adenylate kinase AK2 isoform integral in embryo and adult heart homeostasis

AKT2 Blocks Nucleus Translocation of Apoptosis-Inducing Factor (AIF) and Endonuclease G (endog) While Promoting Caspase Activation During Cardiac Ischemia.

The Akt Pathway Mediates the Protective Effects of Myeloid Differentiation Protein 1 in Pathological Cardiac Remodelling

Amp Activated Protein Kinase-Alpha 2 Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice

Aldehyde Dehydrogenase 2 Deficiency Blunts Compensatory Cardiac Hypertrophy Through Modulating Akt Phosphorylation Early after Transverse Aorta Constriction in Mice.

Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice

Plekhm2 acts as an autophagy modulator in murine heart and cardiofibroblasts